The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16

Lihui Zhang,Mengyuan Li,Feiyan Yuan,Jingyuan Jiang,Xinmin Zhang

DOI: https://doi.org/10.1097/md.0000000000036822

IF: 1.6

2024-01-20

Medicine

Abstract:According to the GLOBOCAN data compiled by the International Agency for Research on Cancer, cervical cancer (CxCa) is currently the fourth most common cancer in women. Approximately 604,000 new cases of CxCa were diagnosed worldwide in 2020 and there were approximately 342,000 deaths attributed to CxCa in the same year. [ 1 ] Human papillomavirus (HPV) infection is the main risk for CxCa and plays a key role in the development of cervical lesions and CxCa. Persistent HPV infection may eventually develop into CxCa. [ 2 , 3 ] HPV infection begins in the basal layer of the stratified squamous epithelium, where the virus replicates initially at a low copy number; when the basal cells differentiate to form the basal layer of the epithelium, the viral genome switches to a high-copy mode, and the virus particles are subsequently released upon epithelial exfoliation, leading to infection of the neighboring cells. [ 4 ] After the integration of the viral genome with the host genome, HPV E6 and E7 early proteins are responsible for the replication of the viral genome, and these can induce cells to transform into cancer cells during the process of viral replication. [ 5 , 6 ] According to its pathogenic ability after infecting skin epithelial cells or inner tissues, HPV can be divided into low-risk and high-risk types. [ 7 ] Some low-risk HPV viruses can cause benign cervical lesions and genital warts, while high-risk HPV plays a key role in the occurrence and development of CxCa. [ 1 ] Infection with high-risk HPV is a commonly observed feature in many patients with CxCa. [ 8 ] Among the high-risk types, HPV16 of mucosal type α is the most frequently detected genotype in 60.5% of CxCa and is classified as a class I carcinogen. [ 9 ]

medicine, general & internal